CD276 and cancer: B7‐H3 has been used as a promising molecular target for various cancer treatment, such as CAR‐T and antibody‐dependent cell‐mediated cytotoxicity [30], indicating the great cancer therapeutic potential of B7‐H3 functional blocking antibody with specific protein–protein interaction target.